Top compounds associated with response to PALMD


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.04 0.3
mRNA TAE684 GDSC1000 pan-cancer AAC 0.062 0.3
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.041 0.3
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA RAF265 CCLE pan-cancer AAC -0.056 0.3
mRNA AZD6244 CCLE pan-cancer AAC 0.05 0.3
mRNA lapatinib GDSC1000 pan-cancer AAC 0.057 0.3
mRNA simvastatin CTRPv2 pan-cancer AAC 0.044 0.3
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.042 0.3
Download CSV